m. drake Et Al. , "safety and efficacy of mirabegron add on treatment to solifenacin in incontinent OAB subjects with an inadequate respose to intial 4 week solifenacin monotherapy," Annual Meeting of the International-Continence-Society , 2015
drake, m. Et Al. 2015. safety and efficacy of mirabegron add on treatment to solifenacin in incontinent OAB subjects with an inadequate respose to intial 4 week solifenacin monotherapy. Annual Meeting of the International-Continence-Society .
drake, m., athanasiou, s., herholdt, c., kaper, m., saleem, t., huang, m., ... siddiqui, e.(2015). safety and efficacy of mirabegron add on treatment to solifenacin in incontinent OAB subjects with an inadequate respose to intial 4 week solifenacin monotherapy . Annual Meeting of the International-Continence-Society
drake, m Et Al. "safety and efficacy of mirabegron add on treatment to solifenacin in incontinent OAB subjects with an inadequate respose to intial 4 week solifenacin monotherapy," Annual Meeting of the International-Continence-Society, 2015
drake, m Et Al. "safety and efficacy of mirabegron add on treatment to solifenacin in incontinent OAB subjects with an inadequate respose to intial 4 week solifenacin monotherapy." Annual Meeting of the International-Continence-Society , 2015
drake, m. Et Al. (2015) . "safety and efficacy of mirabegron add on treatment to solifenacin in incontinent OAB subjects with an inadequate respose to intial 4 week solifenacin monotherapy." Annual Meeting of the International-Continence-Society .
@conferencepaper{conferencepaper, author={m drake Et Al. }, title={safety and efficacy of mirabegron add on treatment to solifenacin in incontinent OAB subjects with an inadequate respose to intial 4 week solifenacin monotherapy}, congress name={Annual Meeting of the International-Continence-Society}, city={}, country={}, year={2015}}